Lectenz Bio receives NIH NIGMS SBIR Phase I
The NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop fucose...
Read moreThe NIH National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase I to develop fucose...
Read moreLectenz Bio attended the ACS Fall 2019 National Meeting, where Dr. Matthew Saunders presented Glycosense™: Simple alternative to existing...
Read moreLectenz Bio founders, Lori Yang and Rob Woods are highlighted in an ASBMB featured story, Setting Sail in a Startup: How academic entrepreneurs...
Read moreChristian Gerner-Smidt and Lori Yang attended the 20th European Carbohydrate Symposium in Leiden, The Netherlands. Dr. Yang gave a lecture...
Read moreLectenz Bio completed the Spring 2019 SBIR NIH I-Corps cohort in Bethesda Maryland! During the 8-week program, our team – Sean Wu (C-Level...
Read moreDr. Lori Yang and Dr. Joshua Renfroe presented posters at the 34th Congress of the International Society for Advancement of Cytometry in...
Read moreDr. Sean Wu and Dr. Joshua Renfroe attend the 13th Jenner Glycobiology and Medicine Symposium in Cambridge, MA. Learn more about the Jenner...
Read moreLectenz Bio has been accepted to the National Institute of Health (NIH) I-Corps program for SBIR phase I awardees. The goal of the program is to...
Read moreDr. Matthew Saunders and Prof. Robert Woods presented two posters, GlycoSense®: A Simple Alternative to Glycosylation Detection and Monitoring...
Read moreSan Diego Glycobiology Symposium CEO and CSO Lori Yang discusses Lectenz Bio products at the annual San Diego Glycobiology Symposium (SDGS) in San...
Read moreGlycoBioTec 2019 Come visit us at our booth! January 28-30, at GlycoBioTec 2019 in Berlin, Germany Rob Woods, Lectenz Bio President gave a talk on...
Read moreRobert J. Woods, Lectenz Bio President and Co-Founder discusses computational biology and its role in drug discovery in the December 2018 Georgia...
Read more